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Abstract.  We have examined the expression of vimen- 
tin during the differentiation of mouse myeloid leuke- 
mia cells (M1),  which were induced to differentiate 
into macrophages by exposure to conditioned medium 
(CM) obtained from rat embryo fibroblasts. The syn- 
thesis of vimentin,  which was examined by two- 
dimensional gel electrophoresis, increased after 
12-24 h of incubation of M1 cells in CM and the 
elevated level of synthesis continued up to 96 h.  A 
macrophage cell line (Mml) that was derived from 
spontaneously differentiated M1 cells constantly syn- 
thesized much higher levels of vimentin.  The amount 
of vimentin,  which was revealed by immunoblot analy- 
sis using an mAb against human vimentin,  also in- 
creased after differentiation by a  factor of 7 when 
compared on the basis of constant protein and by a 
factor of 17 on the basis of constant cell numbers. 
Mml  cells contained >12- and 45-fold more vimentin 
compared with undifferentiated M1  cells on the bases 
of constant protein and constant cell numbers,  respec- 
tively. Northern blot analysis using vimentin cDNA as 
a probe revealed increases in vimentin mRNA in the 
differentiated M1 cells and Mml  cells. Nuclear run-on 
assay showed that the expression of vimentin gene 
during the differentiation of M1 cells was transcrip- 
tionally regulated. 
Observations in indirect immunofluorescence micros- 
copy and EM clearly showed that vimentin bundles 
were rarely observed in undifferentiated M1 cells, and 
increased amounts of and large-size vimentin bundles 
were easily observed in differentiated M1 and Mml 
cells. These results suggest the participation of in- 
creased amounts of vimentin filaments in the maldis- 
tribution of nuclei in M1 cells during differentiation. 
I 
NTERMEDIATE filaments represent a family of cytoskele- 
tal structures whose members are expressed in develop- 
mentally regulated  and tissue-specific  patterns  in ver- 
tebrate cells. There appear to be at least six distinct classes 
of proteins  making  up the various  intermediate  filaments 
(37).  Although the physiological  function of intermediate 
filaments remains obscure, these filaments have been thought 
to play a role in nuclear centralization,  organelle movement, 
and the maintenance  of cell shape (9, 17, 38). Among them, 
vimentin is present in the majority of cells of mesenchymal 
and nonmesenchymal  origin, and its filaments are associated 
with both the nuclear and plasma membranes (9,  17). 
Vimentin mRNA was reported to be increased after stimu- 
lation  by the addition  of serum or growth factor,  such as 
PDGF, but not by the addition of epidermal growth factor nor 
insulin (34).  Vimentin mRNA was not detected in Burkitt's 
lymphoma cells, whereas it was detected in normal lympho- 
cytes and fibroblasts (19). The synthesis of vimentin was also 
reported to be decreased in monkey kidney cells transformed 
by SV-40 and in rat myoblast cells which express the v-mos 
gene (2, 36). 
There are many reports that show the regulation of vimen- 
tin gene expression during differentiation.  Although vimen- 
tin mRNA is found at low levels in immature,  mitotic primi- 
tive erythroid cells of chicken embryo, and accumulates to 
increasingly  higher levels during  terminal  differentiation  of 
the definitive erythroid lineage,  vimentin  mRNA levels de- 
cline during the differentiation of human erythroid cells and 
murine erythroleukemia (MEL) ~ cells (3, 31). 
Mouse  myeloid  leukemia  (M1) cells  were  induced  to 
differentiate  into macrophages  by exposure to conditioned 
medium from rat embryo fibroblasts that contained differen- 
tiation-inducing factors (14). Recently, two cytokines possi- 
bly contained in these conditioned medium, IL 6 and leuke- 
mia inhibitory factor (LIF), have been shown to induce the 
differentiation  in M1 cells (7, 8, 20, 23). Differentiated  M1 
cells are no longer leukemogenic.  During  this  differentia- 
tion,  M1 cells acquire phagocytic  and locomotive activities 
rendering  concomitant quantitative  and qualitative  changes 
in actin and actin-binding  proteins (15, 25, 26, 28, 29, 39). 
In addition to the functional changes,  M1 cells display mor- 
1. Abbreviations  used in this paper: CM, conditioned medium; GAPDH, 
glyceraldehyde 3 phosphate dehydrogenase;  MEL, murine erythroid leuke- 
mia cell line; MI, mouse myeloid leukemia cell line; Mml, macrophage cell 
line; rhIL 6, recombinant human interleukin 6; rhLIE recombinant human 
leukemia  inhibitory factor; TCA,  trichloroacetic acid. 
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filopodia, nuclear maldistribution,  and so forth (12).  Hayashi 
et al.  quantified  the difference in nucleus/cytoplasm  ratios 
before and after differentiation  of M1  cells (11). 
We describe  here marked  changes  in the  expression  of 
vimentin gene during the differentiation  of MI cells in terms 
of synthesis, amount, and mRNA levels. We also show the 
appearance of vimentin bundles in differentiated  M1 cells by 
indirect immunofluorescence microscopy and  EM. 
Materials and Methods 
Cell Line, Culture, and Metabolic Labeling 
The M1 cell line was established from a myeloid leukemia of an SL strain 
mouse and has been maintained in vitro in our laboratory since 1969 (14). 
Ml cells were cultured in DME (Gibco Laboratories, Grand Island, NY) 
with 10% heat-inactivated  horse serum (Cell Culture Laboratories, Cleve- 
land, OH), were morphologically myeioblasts, and were neither motile nor 
phagocytic.. When incubated for several days with various differentiation in- 
ducers, they differentiated into macrophnge-like cells, and acquired motility 
and phagocytic  activity,  accompanied by the induction of other differen- 
tiated functions such as adherence to the substratum and the loss of mitotic 
activity (13, 24, 35). Conditioned medium (CM) was obtained from rat em- 
bryo fibroblasts as described previously  (26), and used at a concentration 
of 10% (vol/vol) to induce the differentiation in MI cells. Recombinant hu- 
man IL 6 was kindly donated from Dr. L Sagara (TOSO Co., Tokyo, Japan), 
and recombinant human LIF was a kind gift from Dr. M. Hozumi (Saitama 
Cancer Center Research  Institute,  Saitama, Japan). 
The Mml line was derived from the MI line and was maintained in vitro 
as macrophage-like  cells (22).  This line showed very active phagocytosis 
without CM incubation.  TheD- line was also derived from the M1 line 
(25) and was not induced to differentiate  into macrophages  when treated 
with CM,  IL 6, or LIE 
For  metabolic  labeling,  1  X  l0  T cells  were  incubated  in  1  ml  of 
methionine-free  DME  for  1  h,  and  then  labeled  with 0.1  mCi/ml  of 
[3SS]methionine, (660.9  Ci/mmol SP act,  New England Nuclear,  Boston, 
MA) for 2 h at 37"C. Cells were washed with PBS three times after labeling 
and lysed in a urea-containing sample solution described by O'Farrell (33). 
Gel Electrophoresis 
One-dimensional SDS-PAGE was performed according to the method of 
Laemmli (16). Cells were washed with PBS and lysed in Laemmli's SDS- 
sample buffer. Aliquots were resuspended in PBS and the protein concentra- 
tion was determined (21). 
Two-dimensional  gel  electrophoresis was performed according to the 
method described by O'Farrell  (33). The gels for the first dimension con- 
tained 1.4% pH 5-8 Ampholine  (LKB Instruments; Gaithersburg, MD) and 
0.6% pH 3.5-10 Ampboline. The concentration  of the SDS-polyacrylamide 
gels used for the second dimension was 4% polyacrylamide  for the stacking 
gels  and  10%  for  the  resolving gels.  Samples  containing equal  TCA- 
precipitable radioactivities were analyzed by two-dimensional  gel  elec- 
trophoresis.  After being fixed in 50% TCA, the gels were immersed in 1 M 
sodium salicylate,  dried, and exposed to x-ray film for fiuorography  (Fuji 
RXO-H  film; Fuji Photo Film Co.  Ltd., Kanagawa, Japan). 
Immunoblot Analysis with Anti-vimentin Antibody 
SDS-polyacrylamide  slab gels were blotted onto nitrocellulose membranes 
as described by Towbin et al. (40).  After incubation in a  10% skim milk 
solution (Yukijirushi  Milk Co.,  Sapporo,  Japan), blotted filters  were  in- 
cubated with mouse mAb against human vimentin (IgM class; Bioyeda, Re- 
hovot, Israel). Guinea pig antibody against mouse ~, and, chains was la- 
beled with Na125I by the chloramine T method, and used as the second an- 
tibody. After autoradiography,  the corresponding vimentin bands were cut 
out, and the radioactivities  were quantitated using a gamma counter (LKB 
Instruments). 
Northern Blot Analysis and Dot Blot Analysis 
Total RN/Ls were extracted from M1 cells with or without CM treatment 
and from Mini cells by guanidine thiocyanateJcesium  chloride methods as 
described by Chirgwin et al. (4). FOly(A)-RNAs were purified by two cycles 
of oligo(dT)-cellulose  column chromatography according to the methods of 
Aviv and Leder (1). 
Total RNAs (10 t~g/lane) or poly(A)-RNAs (1  t~g/lane) were separated 
on 1% agarose gel containing formaldehyde (18), and were transferred onto 
nylon membrane filters (Gene Screen Plus, DuPont/New England Nuclear, 
Boston, MA). Blotted membranes were prehybridized overnight at 42°C in 
5x SSC (Ix SSC, 0.15 M NaCI,  15 mM sodium citrate, pH 7.0) containing 
50% deionized formamide,  2x Denhardt's solution (Ix Denhardt's,  0.02% 
polyvinylpyrolidone,  0.02%  BSA, 0.02% Ficoll), 1% SDS, and 100 ~g/ml 
sonicated-denatured  salmon sperm DNA. A eDNA probe for vimentin, Eco 
R1-Bam HI  1.9-kb fragment of pCV96/I.9EB  plasmid (kindly provided by 
Dr. E. Lazarides,  California Institute of Technology),  was labeled with 32p 
by the multi-prime labeling method as described by Feinberg and Vogelstein 
(5). eDNA probes for/3-actin (a kind girl from Dr. S. Sakiyama,Chiba Can- 
cer Center Research  Institute),  and for glyceraldehyde  3 phosphate de- 
hydrogenase (GAPDH; kindly provided by Dr. M. Hatanaka, Institute for 
Virus  Research,  Kyoto  University)  were  also  labeled  for  control  ex- 
periment. 
Figure 1. Low-power profiles by electron microscopy of MI cells (a), M1 cells treated with 10% (vol/vol) CM for 3 d (b), and Mml cells 
(c).  Cells were fixed,  stained,  and observed as described in Materials and Methods.  Bar in a,  1 ~m. 
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at 42 *C for 16 h in 5 x  SSC containing 50 % deionized formamide,  1  x  Den- 
hardt's, 1% SDS, and 200/zg/ml sonicated-denatured salmon sperm DNA. 
After washing  several times with 2x  SSC at room temperature, 2x SSC 
containing  0.5 % SDS at 65°C, and 0.1 x  SSC at room temperature, the filter 
was exposed at -80"C for 16 h using Fuji RXO-H film with Grenex 8 inten- 
sifying screens (Fuji Photo Film Co.  Ltd.). 
Dot blot analysis was performed as described above after the RNAs were 
blotted onto nitrocellulose membrane filters using a vacuum blot apparatus 
(Bio-Dot; Bio-Rad  Laboratories, Richmond, CA). 
Nuclear Transcriptional Analysis 
M1 cells,  MI cells treated with 10% (vol/vol) CM for 3 d, and Mml cells 
were washed three times with ice-cold  Ix SSC, and incubated in NP-40 ly- 
sis buffer (10 mM Tris-HCI  pH 7.4,  10 mM NaCI,  3 mM MgCI2, 0.5% 
(vol/vol) NP40) for 5 min on ice. After centrifugation at 500 g for 5 min, 
the nuclear pellets were frozen in 50 mM Tris-HCl pH 8.3, 40% (vol/vol) 
glycerol, 5 mM MgCI2, 0.1 mM EDTA. Thawed nuclei were incubated in 
the reaction mixture containing 0.1 mCi of lc¢32PIUTP for the run-on as- 
say described by Greenberg and Ziff (10). An equal amount of 32p-labeled 
RNA, in terms of counts per minute, was hybridized with each eDNA im- 
mobilized on nitrocellulose membranes. For nitrocellulose  binding, linear- 
ized  plasmids by restriction enzyme digestion were denatured by NaOH 
treatment, and spotted onto nitrocellulose  filters using the vacuum blot ap- 
paratus.  I0/~g DNA was applied per dot. 
Indirect lmmunofluorescence Microscopy 
Cells were attached to glass slides using cytospin, fixed with 4% parafor- 
maldehyde in PBS at 4"C for 5 rain, and washed in PBS three times.  After 
brief permeabilization with 0.2 % Triton X-100 in PBS for 10 min at room 
temperature, cells were incubated in anti-vimentin  antibody for 1 h at room 
temperature.  Cells  were washed three times with PBS,  incubated with 
FlTC-labeled second antibody (rabbit anti-mouse lgM; Zymed Corp., San 
Francisco,  CA)  for  I  h,  washed  again,  and then observed by  means of 
fluorescence  microscopy  (Nikon, Tokyo, Japan). 
Electron Microscopy 
Cells were fixed with 2.5 % glutaraldehyde in 0.1 M phosphate buffer (pH 
7.2) at room temperature for 2 h, and then treated with 7% sucrose in 0.1 M 
phosphate buffer overnight at 4"C. After washing with phosphate buffer, the 
cells were postfixed with 1% osmium in 0.1 M phosphate buffer for 1 h at 
40C. Cells were dehydrated  with serial concentrations of ethanol (50, 70, 
90, and 100%) at 4°C, again with 100% ethanol at room temperature, and 
finally  with  propyrene  oxide.  After  being  embedded  in  Lubea  K812 
(Nacalai Tesque, Kyoto, Japan), thin sections were prepared using an ultra- 
microtome (Ultrotome 2088; Pbarmacia LKB, Uppsala,  Sweden),  stained 
with uranyl acetate and lead actinal¢, and were observed using a JEM100CX 
type electron microscope  (JOEL,  Tokyo, Japan). 
Results 
Morphological Changes in M1 Cells during 
Differentiation 
Undifferentiated M1  cells are  small leukemic myeloblasts 
with large and round nuclei when observed by EM (Fig.  1 
a),  or  by  microscopy after  staining the ceils  with May- 
Griinwald-Giemsa solution (data not shown; see references 
11  and 14). After incubation for 2 or 3 d in the CM from 
rat embryo fibroblasts containing the differentiation-induc- 
ing factor, M1 cells were induced to differentiate into macro- 
phages. Differentiated M1 cells treated with CM for 2 or 3 d 
and Mml ceils, which are macrophage-like cells originating 
from spontaneously differentiated M1  cells were also ob- 
served by electron microscopy (Fig. 1, b and c). In differen- 
tiated cells, the size of the cells increased and cells became 
irregular in shape with numerous villiary projections and 
blebs of the cytoplasm, philopods,  and creeping pseudopods. 
The nuclei seemed to be deeply indented and polymorphic. 
The cytoplasm of CM-treated cells became more hypertro- 
phic with an increase in the number of organeUes. Mml cells 
seemed similar to CM-treated M1 cells, and large filamen- 
tous bundles were often found when observed even by low- 
power electron microscopy (Fig. 1 c, arrowhead). As typi- 
cally seen in macrophages, nuclei in differentiated MI and 
Mml cells were squeezed into one side of the cell. 
Figure 2.  Two-dimensional analysis of the extract from MI cells (A), MI cells treated with CM (B), and Mml  cells (C).  MI  and Mml 
cells and M1 cells incubated with  10%  (vol/vol) CM for 3 d  were labeled for 2  h  with 0.1  mCi/ml of [3SS]methionine. Cells were lysed 
in the lysis buffer described by O'Farreil (33), and aliquots of the cell lysate containing equal amounts of TCA-precipitable radioactivity 
were analyzed by two-dimensional gel electrophoresis consisting of isoelectric focusing as the first dimension (right to left) and SDS-10% 
polyacrylamide  slab gels as the second dimension (top to bottom).  Arrowheads indicate the position of vimentin. A,  actin. 
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nine for 2 h at various times after the treatment with  10%  (vol/vol)  CM, and lysed in O'Farrell's lysis buffer.  Aliquots containing equal 
amounts of TCA-precipitable radioactivity were analyzed as described in Fig.  2.  Untreated M1 cells and Mml cells were also analyzed 
as controls.  Arrowheads indicate the position of vimentin. A, actin. 
Induction of Vimentin during Differentiation 
M1 cells, CM-treated M1 cells, and Mml cells were labeled 
with  [35S]methionine,  and  the  total  cell  lysates  were  ana- 
lyzed by two-dimensional gel electrophoresis.  In addition to 
several differences in the spots among these three cell lysates 
on  two-dimensional  gels,  the  synthesis  of  vimentin  was 
clearly observed to increase after the differentiation  of M1 
Figure 4. Immunoblot analysis of vimen- 
tin induction.  MI cells (lane 1), MI cells 
treated with  10%  (vol/vol) CM for 3 d 
(lane 2),  and Mml  cells (lane 3) were 
washed with PBS and lysed in Laemmli's 
SDS-sample buffer. Aliquots of the cells 
were  suspended  in  PBS,  sonicated  for 
20 s three times at the maximum setting 
of the ultrasonic  generator (Kaijo Denki, 
Ltd., Tokyo, Japan), and the protein con- 
centration of the lysate was determined 
by Lowry's method (21).  After electro- 
phoresis using SDS-10% polyacrylamide 
slab gels containing DTT, blotting of the 
protein was performed according to the 
method of Towbin et al.  (41).  Anti-hu- 
man vimentin mAb (IgM; Bioyeda) was 
used at a dilution of  2,000-fold, and then 
detected  by  ~25I-labeled anti-mouse  # 
and r chain antibody (guinea pig). Fuji 
RXO-H x-ray film was used for autora- 
diography. 
cells (Fig.  2).  The synthesis of vimentin in Mml  cells was 
higher  than  that  in  CM-treated  MI  cells.  The  kinetics  of 
vimentin  synthesis induction  was examined by treating  the 
cells  with  CM  and  by  labeling  with  [35S]methionine  at 
different times after CM treatment (Fig. 3). Control M1 cells 
synthesized only a trace amount of vimentin, and the synthe- 
sis of vimentin increased at 12-24 h after CM treatment. Af- 
ter the synthesis reached a maximum level at 48 h, the high 
level of vimentin  synthesis continued  up to 96  h. 
The amount of vimentin was examined by using immuno- 
blot analysis with mAb against vimentin.  Fig.  4  shows that 
the amount of vimentin was increased after differentiation of 
M1 cells while only a trace amount of vimentin was detected 
in undifferentiated M1 cells. The amount of vimentin in Mml 
cells was further  increased  as was the case with  synthesis. 
Time-course  analysis  of  vimentin  accumulation  in  the 
cytoplasm  was also performed  by  immunoblot  analysis  at 
different times after CM treatment.  Each band of vimentin 
on  the  filter  detected  by  immunoblot  analysis  at  different 
times  was  excised  and  the  radioactivity  was counted  by a 
gamma counter to quantify the amount of vimentin. As seen 
in Fig. 5, the amount of vimentin was rapidly increased after 
6-12 h of CM treatment, reached a peak at 48-72 h, and then 
decreased.  The increase in CM-treated M1 cells at the peak 
was over sevenfold higher than nontreated control M1  cells 
when an equal amount of protein was applied to SDS-PAGE, 
and over 17-fold higher when compared on the basis of equal 
cell numbers.  The amounts of vimentin in Mml  cells were 
>12-  and  45-fold  higher  compared  with  those  in  undiffer- 
entiated M1 cells on the bases of equal protein and equal cell 




i  ,?; 
1, 
0  612  24  48  7  mmml 
Been Mter Cmm Treetmeet 
8  'r 
iii 
\  a  2o8_. 
\  | 




I  [  ! 
0  612  24 
b 
I 
40  72  96 nil 
Allor on Tronlmont 
Figure 5. Kinetics  of vimentin accumu- 
lation after the incubation of MI cells 
with  CM.  M1  ceils  were  lysed  in 
Laemmli's SDS-sample buffer at various 
times  after  the  treatment'with  10% 
(vol/vol) CM and analyzed by immuno- 
blotting as described in Fig. 4. Vimentin 
bands on the dried gel were cut out by 
superimposing the  x-ray  film,  and the 
radioactivity  was counted by a gamma 
counter (Pharmacia LKB). A is the re- 
sult  of electrophoresis  by adjusting  the 
amount of protein to be applied  to the 
gels, and b is the result obtained by ad- 
justing the cell numbers per lane.  The 
abscissa  indicates  the relative  increase 
in vimentin by normalizing the amount 
of vimentin in nontreated  MI cells to 1. 
The amounts of vimentin in Mml cells 
are indicated by bars at the right side of 
each figure. Adherent (,4) and nonadher- 
ent  (N)  M1  cells were separately  col- 
lected at the fourth and fifth day of incu- 
bation,  and  the  amounts  of vimentin 
were determined as above. 
numbers,  respectively (see bars in Fig. 5).  The differences 
in induction between equal protein and equal cell numbers 
were due to the protein contents per cell.  Differentiated M1 
cells and Mml cells contained approximately two- and four- 
fold higher levels of protein per cell, respectively, when com- 
pared with nontreated M1 cells. The decrease in the amount 
of vimentin after 3 d of incubation with CM appeared to be 
due to cell death, because the vimentin content did not de- 
crease when only the cells  adhering to the dish were ana- 
lyzed (Fig. 5).  The viability and phagocytosis of nonadher- 
ent cells,  consisting of both undifferentiated  ceils and dead 
cells,  were lower than those of adherent cells.  The content 
of vimentin of nonadherent ceils was markedly low at 96 h 
of incubation. 
To exclude possible influence of unknown factor(s) in CM 
on the expression of vimentin regardless of differentiation, 
we examined the effect of IL 6 and LIF, two differentiation- 
inducing factors for M1 cells, on the expression of vimentin 
in MI cells and also the effect of CM on that in D- subline 
of M1 cells, which is resistant to IL 6 and LIF as well as in 
Balb/3T3  cells.  As shown in Fig.  6,  the  level of vimentin 
in M1 ceils treated with 1,000 U/ml rh (recombinant human) 
IL 6  for 3  d  was similar  to that of cells treated  with CM. 
Recombinant hLIF also induced vimentin in M1 cells (data 
not shown).  On the other hand,  CM did not influence the 
amount  of vimentin  accumulated  in  D- cells  or Balb/3T3 
cells. 
Figure 6. Effect of IL-6 on the amount of vimentin in M1 cells and 
effect of CM on that in D- cells and Balb/3T3 cells.  MI cells were 
treated  with 10% (vol/vol) CM or with 1,000 U/ml rhlL 6 for 3 d. 
D- cells or Balb/3T3 cells were treated with 10% (vol/vol) CM for 
3 d. The amount of vimentin was determined on the basis of equal 
protein concentration as described in Fig. 4. Lane 1, M1 cells with- 
out treatment;  lane 2, M1 cells treated  with CM; lane 3, M1 cells 
treated with rhlL-6, lane 4, D- cells without treatment;  lane 5, D- 
cells  treated  with CM; lane  6, Balb/3T3  cells  without treatment; 
and lane  7, Balb/3T3  cells  treated with CM. 
Transcriptional Regulation of Vimentin Expression 
Next, we examined the induction of vimentin at the mRNA 
level.  Total RNAs isolated from undifferentiated  MI, CM- 
treated M1 and Mml cells were electrophoresed under dena- 
tured conditions with formamide, blotted onto nylon mem- 
branes,  and  hybridized  with  cDNA  for  chick  vimentin. 
RNAs were also hybridized with eDNA for mouse ~-actin 
and GAPDH as controls. Fig. 7  C clearly shows the induc- 
tion of mRNA for vimentin  in differentiated  M1  cells and 
Mml cells. In differentiated M1 cells and Mml ceils, mRNA 
levels  for  ~t-actin  were  1.3-2.0-fold  higher  than  that  in 
undifferentiated MI cells, which coincides with our previous 
results at the protein level (25). Fig. 7 also shows that mRNA 
levels for GAPDH did not change during the differentiation. 
Because the size of  vimentin mRNA was '~2.1 kb, which was 
equal to that of 18S ribosomal RNA, we further checked the 
induction of vimentin mRNA by using oligo(dT) cellulose- 
purified  mRNAs for Northern blot analysis to exclude the 
possibility of cross-reaction with 18S ribosomal RNA. The 
induction of  vimentin mRNA after differentiation of M1 cells 
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regulated at the transcriptional level, we performed a nuclear 
run-on assay by labeling the nucleus with a-[32p]-UTP, and 
by hybridizing the labeled mRNA in the nucleus with cDNA 
Figure 7. Detection of vimentin mRNA in MI cells,  MI cells  in- 
cubated with CM, and Mml cells.  (A, B, and C) Total RNA was 
isolated by the methods of Chirgwin et al.  (4) from M1 cells (lane 
1), M1 cells treated  with 10% (vol/vol) CM for 3 d (lane 2), and 
Mml cells (lane 3). (D) Poly(A)-RNA was further purified by two 
cycles of oligo(dT)-cellulose  column chromatography according to 
the procedure of Aviv and Leder (1). Lane 1, poly(A)-RNA from 
M1 cells; lane 2, poly(A)-RNA from CM-treated M1 cells.  Total 
RNA and POly(A)-RNA were separated on 1% agarose gel contain- 
ing formaldehyde, transferred  onto nylon membrane filters, and hy- 
bridized  with 32p-labeled cDNAs for GAPDH (A),  /3-actin (B), 
and vimentin (Cand D) as described in Materials and Methods. Ar- 
rowheads  indicate  28S and  18S ribosomal RNA bands. 
was  confirmed  by  Northern  blot  analysis  using  purified 
mRNAs (Fig.  7/9). 
The kinetics of vimentin mRNA accumulation were exam- 
ined by using total RNAs isolated from M1 cells at different 
times after CM treatment by Northern blot analysis (Fig. 8, 
A and B) and by dot blot analysis (data not shown). Control 
MI cells and Mml  cells were also assayed as negative and 
positive controls, respectively.  As shown in Fig.  8, mRNA 
levels  for vimentin increased after  12 h  of CM treatment, 
with the peak occurring after 48 h. When both adherent and 
nonadherent  cells  were  collected  together,  the  levels  of 
vimentin mRNA were found to have decreased after 48 h of 
incubation. This decrease might be due to the cell death be- 
cause of prolonged culture of differentiated M1 cells without 
medium  change.  Thus,  we  collected  only  adherent  cells 
whose viability was >90%. The level of vimentin mRNA in 
these cells decreased only slightly after 72 or 96 h. 
The amount of vimentin mRNA in Mml cells was also ex- 
amined by Northern blot analysis and quantitated by dot blot 
analysis  (Fig.  8).  When  Mml  cells,  which  are  adherent 
macrophage-like cells, were collected after reaching conflu- 
ence, their level of vimentin mRNA was higher than that of 
undifferentiated  M1  cells,  but  significantly  lower than the 
maximum level in CM-treated M1  cells.  However, the level 
of vimentin mRNA in Mml cells collected from the sparse 
culture was slightly higher than the maximum level in CM- 
treated M1  cells. 
Figure  8.  Kinetics  of  vimentin  mRNA  induction  during  the 
differentiation  of MI cells.  Total RNAs prepared from the cells at 
various times of incubation with 10% (vol/vol) CM were separated 
on 1% agarose gel as described in Fig. 7, and the amount of vimen- 
tin  mRNA  was  detected  with  a  32p-labeled cDNA  probe  for 
vimentin (A). Total RNAs were also prepared from only adherent 
cells obtained on the fourth and fifth day of incubation  with CM, 
and the amount of vimentin mRNA was  detected  as above  (B). 
Mml  cells  were inoculated  at the density  of 3  x  10  6 cells/dish 
(9 cm in diameter),  and collected  at the third day (Mml in Fig.  8 
B), or at the sixth day (Mini in Fig. 8, A). The medium of the latter 
culture of Mml cells was changed at the third day. Total RNAs were 
serially  diluted  and blotted onto nylon membrane filters, then hy- 
bridization  was  performed using a  32p-labeled cDNA probe for 
vimentin.  Each spot on the filter was excised and the radioactivity 
was counted. By using the linear portion of the radioactivity in the 
serially  diluted  sample,  the  induction  kinetics  were determined 
(C). M/indicates the RNA isolated from nontreated  MI cells, and 
MmJ  from Mml cells.  The dotted line in Fig.  8 C indicates  the 
amount of vimentin mRNA in the adherent cells.  In Fig.  8 C, the 
abscissa  indicates  the relative  increase  in vimentin mRNA where 
the amount of vimentin mRNA of nontreated  MI cells was normal- 
ized to the value  1. 
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differentiation. Vimentin eDNA bound to nitrocellulose filters was 
hybridized  with  32P-labeled run-on  transcripts  in nuclei  isolated 
from nontreated M1 cells (1), CM-treated  MI cells (2), and Mml 
cells  (3).  Vector DNA (pSP65)  was blotted  onto nitrocellulose 
filters, and analyzed similarly  for control experiment. 
for vimentin  which  was blotted onto  nitrocellulose  mem- 
brane filters. The transcripts were clearly increased in CM- 
treated cells and Mml cells (Fig. 9), suggesting that the in- 
duction of vimentin during the differentiation of MI cells was 
transcriptionally regulated. 
Appearance of Vimentin Bundles after Differentiation 
Indirect immunofluorescence observation was performed by 
using an mAb against human vimentin for undifferentiated 
M1, CM-treated M1, and Mml cells. Whereas M1 cells were 
not stained or very weakly stained if any, CM-treated M1 
cells contained strongly stained filamentous structures (Fig. 
10).  The intensity of the staining was drastically increased 
in  Mml  cells.  The  nuclei  in  some Mml  cells  seemed to 
be surrounded  by networks consisting of thick bundles of 
vimentin, and others showed strong staining of vimentin at 
the one side of the cytoplasm (Fig.  10f). 
Electron microscopic observations at high magnitudes re- 
vealed the differences in vimentin bundles among these three 
cells. We hardly detected vimentin bundles in undifferenti- 
ated MI cells. Fig.  t 1 a  shows a small cluster of wavy illa- 
ments, the diameter of which was ~10 am, in undifferentiated 
M1 cells. However, it was very hard to find such clusters in 
undifferentiated  M1  cells,  and  the  possibility of detecting 
such clusters of vimentin was below 1 out of 50 thin section 
pieces of the ceils searched.  During differentiation,  it be- 
came very easy to detect vimentin bundles in the cells. Fig. 
11 b shows bundles of vimentin in ceils treated with CM for 
3 d. The sizes of the bundles were larger than those in M1 
cells. The sizes and the frequency of vimentin bundles be- 
came more prominent during the prolonged incubation with 
CM (Fig.  11 c, 4 d incubation). In Mml cells, large parts of 
the cytoplasm were occupied by vimentin bundles (Fig.  11 
d).  Almost all thin section preparations of Mml  cells had 
such prominent bundles. 
These biochemical and  morphological observations de- 
scribed  above were  consistent,  and  clearly  indicated  that 
vimentin synthesis was induced and that thick bundles were 
Figure 10.  Immunofluorescence  micro- 
scopic observation of  vimentin. MI cells 
(a and  b),  MI  cells  treated  with  10% 
(vol/vol) CM for 3 d (c and d), and Mml 
ceils (e and f) were attached to the glass 
slides  by cytospin  centrifugation,  and 
fixed with 4% paraformaldehyde. After 
brief permeabilization,  cells  were  in- 
cubated  with  anti-vimentin  antibody, 
then  with  FITC-labeled  anti-mouse 
IgM. (a, c, and e) Phase contrast.  (b, d, 
and f) Indirect immunofluorescence mi- 
croscopy. 
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graph of M1  cells. (a) Nontreated MI 
cells;  (b)  M1  cells  treated  with  10% 
(vol/vol)  CM for 3 d; (c) MI cells treated 
with CM  for 4 d; and (d) Mml  cells. 
Bar,  l #m. 
formed during the differentiation of myeloblastic leukemia 
cells. 
Discussion 
When incubated for 2 or 3 d with CM containing differen- 
tiation-inducing factor, M1  cells were induced to differen- 
tiate into  macrophages,  and  acquired the  locomotive and 
phagocytic activities (14,  15).  The differentiation inducing 
factor was purified from the CM of L929 cells (40), and re- 
cently, the cDNAs have been cloned from murine and human 
cells (7,  8, 20).  IL 6 has also been reported to induce the 
differentiation in M1  cells (23). 
The acquisition of these activities might be attributable to 
changes in the actomyosin system. We reported quantitative 
and qualitative changes in actin during the differentiation of 
M1 cells where the qualitative changes in actin such as poly- 
merization and  the  B/-y ratio  of cytoplasmic actin,  were 
marked rather than the quantitative changes (25,  26).  We 
have identified three actin binding proteins in M1 cells; one 
inhibits the polymerization of actin (27), and the two others 
cause the monovalent-cation sensitive gelation of actin fila- 
ments (28,  39). These three factors have all been purified. 
Besides these changes, differentiated MI cells reveal char- 
acteristic morphological changes. The sizes of cells are en- 
larged, and the ratio of nucleus to cell gradually decreases 
during the differentiation of M1 cells (12), which was quanti- 
tized by Hayashi et al. (I l). The nuclei are squeezed into one 
side of the cytoplasm in differentiated cells (CM-treated MI 
cells and Mml cells) which was observed by May-Griinwald- 
Giemsa staining or by electron microscopy (Fig. 1). Because 
this maldistribution of nuclei is now thought to be sustained 
by intermediate filaments (for a review, see Lazarides [17]), 
it should be interesting to examine changes in the expression 
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cells. 
In this paper, we reported that vimentin expression was en- 
hanced after the differentiation of M1 cells at the levels of 
protein synthesis,  protein content,  and mRNA  accumula- 
tion. This induction of vimentin was regulated at the level 
of transcription. The maldistribution of the nuclei in differ- 
entiated M1 cells, which have been reported previously (11, 
12), might be partly explained by this induction and accumu- 
lation of vimentin, and the formation of vimentin bundles af- 
ter differentiation. Although the increases in vimentin com- 
pared on the basis'of equal protein were >7-fold higher after 
48-72 h of incubation with CM and >12-fold higher in Mml 
cells, the increases were >17-fold higher in CM-treated MI 
cells and >45-fold higher in Mml cells when compared on 
the basis of equal cell numbers. The differences in these in- 
creases were due to differences in total protein content be- 
fore and after differentiation, which we have already report- 
ed (25). 
The increase in the amount of vimentin was not caused 
only by culturing M1 cells with CM, but also by the treat- 
ment with IL 6 and LIF, which induce the differentiation in 
M1 cells (7, 8, 20, 23). The amount of vimentin in D- cells 
and Balb/3T3 cells was not increased by the treatment with 
CM. These findings suggest that the increase in vimentin is 
the result of M1 cell differentiation, and not the direct effect 
caused by unknown factor(s) in CM. 
We found that the level of vimentin mRNA in Mml cells 
collected from confluent culture was lower than that from 
sparse culture. This observation suggests that the expression 
of vimentin  is  partly  associated  with  growth  conditions, 
which is consistent with the finding that the steady-state lev- 
els  of cytoplasmic vimentin mRNA  in  3T3  cells  are  in- 
creased  by  addition  of serum  (6).  Although  the  level of 
vimentin mRNA in confluent Mml cells was lower than that 
of the maximum level of CM-treated M1 cells, the level of 
vimentin mRNA in Mml cells collected from sparse culture 
is a little higher than that. 
When all cells were collected for the analysis of vimen- 
tin content by immunoblot and of vimentin mRNA by North- 
ern blot, the amount of vimentin and the level of vimentin 
mRNA were decreased at the fourth day of incubation with 
CM.  These decreases may be attributable to the cell death 
caused by prolonged culture  without medium  change be- 
cause neither the amount of vimentin nor that of vimentin 
mRNA decreased when assayed by collecting only adherent 
cells, and because the amount of vimentin of nonadherent 
cells was much lower than that of adherent cells. When the 
medium was changed at the third day of incubation, and ad- 
herent cells were further cultured without CM, the amount 
of vimentin increased nearly 40-fold of that of undifferenti- 
ated M1 cells at the fifth day (data not shown). These results 
suggest that the induction of vimentin during the differentia- 
tion of M1 cells is not a transient phenomenon, but is closely 
related to cell differentiation. 
The  increase  in  the  amount  of  vimentin  after  CM- 
treatment seemed to precede those in the induction of vimen- 
tin mRNA and the synthesis of vimentin (Figs. 3, 5, and 8). 
These results suggest either the stabilization of vimentin or 
the decrease in vimentin degradation activities occurred im- 
mediately after the incubation of M1  cells with CM.  Re- 
cently,  we  found  Ca2+-independent  protease  activity  in 
undifferentiated M1  cells in addition to a  Ca2+-dependent 
protease called calpain or CANP (manuscript in prepara- 
tion).  Interestingly, only Ca2÷-dependent  protease activity 
was detected in differentiated M1 and Mml cells. We are now 
characterizing the nature of this new type of protease. 
The  size  of mRNA  in  M1  cells  was  ,~2.1  kb,  which 
comigrated with  18S  ribosomal RNA bands,  and did not 
change before or after differentiation (Fig. 7). The band de- 
tected by vimentin cDNA hybridization was not an artifact 
due  to  cross-reactivity  with  ribosomal  RNA,  because 
poly(A)-RNA purified by two cycles of oligo(dT)-cellulose 
affinity chromatography was also detected by the Northern 
blotting method at the same position and at the same density. 
The nuclear run-on assay revealed that the increase in the 
amount of vimentin mRNA was not due to a decrease in the 
turnover  rate,  but  was  due  to  increased  transcription  of 
vimentin mRNA after CM-treatment. 
The regulation of vimentin expression has been reported 
to be closely related to differentiation (3, 31), growth (5) and 
transformation (2, 19, 36) in various cells. Vimentin expres- 
sion is inhibited in monkey kidney cells infected with SV-40 
(2), and vimentin mRNA  is not detected in Burkitt's lym- 
phoma  by  Northern  hybridization using  vimentin  cDNA 
(19). Treatment of HL60 cells, human promyelocytic leuke- 
mia line cells, or K562 cells, human erythroleukemic line 
cells, with 12-O-tetradecanoyl-phorbol 13-acetate (TPA) is 
reported to cause the induction of  vimentin mRNA, although 
the treatment of HL60 ceils with retinoic acid has the oppo- 
site effect (6). Lazarides and his colleagues reported the spe- 
cies specific expression of vimentin genes using the differen- 
tiation system of chick and murine erythroid cells (3,  31). 
Vimentin synthesis is increased during the differentiation of 
chick erythroid precursors, whereas it decreases after the 
maturation of mammalian erythrocytes. This might reflect 
the  phenomenon  in  which  mammalian  erythrocytes lose 
their nuclei  during  maturation.  Interestingly,  when chick 
vimentin gene is introduced into MEL ceils, the expression 
of  vimentin  mRNA  is  enhanced  during  differentiation, 
whereas  similarly transfected hamster vimentin genes are 
negatively regulated (32). 
Various  markers  for detecting the differentiation of M1 
cells have been reported including the induction of phagocy- 
tosis (15),  motility (24),  lysosomal enzymes (30), the de- 
crease in  tumorigenicity, and morphological changes  (13, 
35). The induction of vimentin expression additionally pro- 
vides one of the clear markers for identifying differentiation 
of the M1 cell line at the protein and mRNA levels. We are 
now analyzing vimentin genes, especially its promoter re- 
gion. The identification of cis-acting  transcriptional elements 
and transcriptional factors may be important in understand- 
ing myeloid differentiation at the molecular level. 
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